| Writing group member | Employment | Research grant | Other research support | Speakers’ bureau/honoraria | Expert witness | Ownership interest | Consultant/advisory board | Other |
|---|---|---|---|---|---|---|---|---|
| Donald M. Lloyd-Jones | Northwestern University Feinberg School of Medicine | None | None | None | None | None | None | None |
| Norrina B. Allen | Northwestern University Feinberg School of Medicine | NIH†; AHA† | None | None | None | None | None | None |
| Cheryl A.M. Anderson | UCSD | None | None | None | None | None | WW†; McCormick Science Foundation† | None |
| Terrie Black | University of Massachusetts College of Nursing | None | None | None | None | None | None | None |
| LaPrincess C. Brewer | Mayo Clinic College of Medicine | AHA*; NIH*; CDC*; ACC* | None | None | None | None | None | ABC*; ACC*; Am J Prev Card*; J Am Med Assoc* |
| Randi E. Foraker | Washington University in St. Louis, School of Medicine | NIH/NCI (1R01CA226078)† | None | None | None | None | None | None |
| Michael A. Grandner | University of Arizona College of Medicine | None | None | None | None | None | None | None |
| Helen Lavretsky | UCLA | NIH (PI)†; PCORI (PI)†; NCCIH† | None | None | None | None | None | None |
| Amanda Marma Perak | Lurie Children’s Hospital and Northwestern University | NHLBI (K23 grant that examines molecular mechanisms of CVH in children)†; Northwestern University (multiple small pilot grants investigating CVH in pregnant people and youth)† | None | None | None | None | None | None |
| Wayne Rosamond | University of North Carolina Gillings School of Global Public Health | None | None | None | None | None | None | None |
| Garima Sharma | Johns Hopkins University School of Medicine | None | None | None | None | None | None | None |
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*
Modest.
†
Significant.